Internal Medicine, Infectious Disease · Fort Worth, TX
NPI
1265407761
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1124 College Ave
Fort Worth, TX, 76104
Phone (817) 348-0821
Groups this clinician bills Medicare through
Medicare paid, 2024
$415K
41,498 services
Medicare patients, 2024
460
Average age 71
Drug cost, 2024
$2.3M
1,403 prescriptions
Company payments, 2025
$1,151
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark J Hupert was code 99232 (hospital e&m - subsequent), 857 times for 264 patients. In total Mark J Hupert billed 41,498 services in 49 codes, and Medicare paid $415K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 857 | 264 | $65.72 | $56K |
| 99233 Hospital E&M - Subsequent | Facility | 523 | 223 | $98.83 | $52K |
| 96365 Intravenous Infusion, Hydration | Office | 221 | 20 | $51.68 | $11K |
| 99223 Hospital E&M - Initial | Facility | 168 | 158 | $144.40 | $24K |
| 99214 Office E&M - Established | Office | 136 | 68 | $106.92 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 129 | 71 | $13.65 | $1,761 |
| 99231 Hospital E&M - Subsequent | Facility | 93 | 51 | $41.54 | $3,863 |
| 99222 Hospital E&M - Initial | Facility | 92 | 78 | $109.64 | $10K |
| 99215 Office E&M - Established | Office | 36 | 27 | $141.45 | $5,092 |
| 36573 Venous Catheter Insertion | Office | 15 | 13 | $305.99 | $4,590 |
| 99205 Office E&M - New | Office | 11 | 11 | $178.81 | $1,967 |
By year: 2022 $427K for 18,910 services; 2023 $298K for 9,669 services; 2024 $415K for 41,498 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark J Hupert prescribed most often to Medicare patients was Ertapenem (Ertapenem Sodium), with 89 prescriptions and refills. In total Mark J Hupert wrote 1,403 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ertapenem Ertapenem Sodium | 89 | 89 | 29 | $39K |
| Ceftriaxone Ceftriaxone Sodium | 86 | 86 | 25 | $9,596 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 74 | 74 | Under 11 | $298K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 59 | 59 | Under 11 | $260K |
| Daptomycin Generic | 58 | 58 | 17 | $30K |
| Cutaquig Immun Glob G(Igg)-Hipp/Maltose | 42 | 42 | Under 11 | $232K |
| Vancomycin Hcl Generic | 40 | 40 | 17 | $6,897 |
| Azithromycin Generic | 40 | 48 | 12 | $678 |
| Minocycline Hcl Generic | 40 | 45 | Under 11 | $789 |
| Cefepime Hcl Generic | 39 | 39 | 15 | $4,699 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 39 | 39 | Under 11 | $166K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 38 | 40 | Under 11 | $188K |
| Meropenem Generic | 28 | 28 | 11 | $5,795 |
| Darunavir Generic | 28 | 28 | Under 11 | $33K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 27 | 30 | Under 11 | $1,031 |
Brand drugs: 464 claims; generic drugs: 939 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark J Hupert $1,151 ($1,151 in general payments such as food, travel and fees) from 15 companies. The largest payer was ViiV Healthcare Company with $327.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 15 | $327 |
| Paratek Pharmaceuticals, Inc. | 8 | $161 |
| Gilead Sciences, Inc. GILD | 6 | $142 |
| Theratechnologies Inc. THTX | 3 | $74.91 |
| Abbvie Inc. ABBV | 3 | $72.06 |
| Melinta Therapeutics, LLC | 3 | $71.48 |
| Insmed, Inc. INSM | 3 | $61.23 |
| Aimmune Therapeutics, Inc. | 2 | $54.56 |
| Merck Sharp & Dohme LLC MRK | 2 | $45.47 |
| Octapharma USA, Inc. | 1 | $28.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.